“…They are involved in the differentiation and proliferation of mesenchymal tissues during embryonic development (16). Some lipomas, angiomyxomas, and uterine leiomyomas harbor a translocation involving HMGA2, at 12q15, which leads to a chimeric fusion product with different partners (15,(17)(18)(19). Translocations involving HMGA1 are identified in a subset of lipomas and uterine leiomyomas, including benign uterine metastasizing leiomyoma, which results in an upregulated expression of the chimeric protein (16,(20)(21)(22).…”